Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by Ohlbe – France, 2020-04-20 12:11 (1458 d 06:04 ago) – Posting: # 21337
Views: 2,659

Dear Silvia,

❝ Could the Clinical step of a BE study (screening, recruiting, administration of formulations and blood samples extractions) be carried out maintaining the HV at their own homes (always with a nurse at all times and a medical doctor visiting all the volunteers, etc etc)?


Besides what you already mention (certification of clinical centres), I see several hurdles and I don't think what you propose would be feasible/acceptable for ethics committees and authorities:
Sorry but I think all we can do is be patient...

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,985 posts in 4,823 threads, 1,654 registered users;
44 visitors (0 registered, 44 guests [including 7 identified bots]).
Forum time: 18:16 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5